NextGen Sciences this week launched its plasmabreast25 multiplex protein assay for the discovery and quantification of protein biomarkers linked to breast cancer.
The assay uses multiple-reaction monitoring mass spectrometry to simultaneously measure 25 proteins in plasma samples. The product is the latest in NextGen's line of biomarker discovery panels, the first of which — plasmadiscover41 — it launched last month.
Berg Diagnostics has released 100 ELISA kits for research use. The kits cover a variety of protein families including cytokines, growth factors, and receptor proteins and a number of research areas like inflammation, oncology, and immunology.